Last update 01 Nov 2024

DiverDrugs SL

Subsidiary Company|
Spain
|
www.diverdrugs.com

Overview

Tags

Nervous System Diseases
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Synthetic peptide1
Top 5 TargetCount
TRPV1(Transient receptor potential cation channel subfamily V member 1)1

Related

6
Drugs associated with DiverDrugs SL
Parentide
Target
TRPV1
Mechanism
TRPV1 antagonists
Active Org.
DiverDrugs SL
Originator Org.
DiverDrugs SL
Active Indication
Neuralgia
Inactive Indication
Cancer Pain
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
DD-612
Target-
Mechanism-
Active Org.-
Originator Org.
DiverDrugs SL
Active Indication-
Inactive Indication
Alzheimer Disease [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
DD-20207
Target
NMDA receptor
Mechanism
NMDA receptor antagonists
Active Org.-
Originator Org.
DiverDrugs SL
Active Indication-
Inactive Indication
Alzheimer Disease [+2]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with DiverDrugs SL
Login to view more data
0 Patents (Medical) associated with DiverDrugs SL
Login to view more data
100 Deals associated with DiverDrugs SL
Login to view more data
100 Translational Medicine associated with DiverDrugs SL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
5
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Parentide
 ( TRPV1 )		Neuralgia
More
Phase 2
DD-snn12
Dystonia
More
Pending
DD-20164
Bacterial Infections
More
Pending
DD-612
Parkinson Disease
More
Pending
DD-B4
 ( NMDA receptor )		Dementia
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free